Cargando…

The Association Between Foxp3 Polymorphisms and Risk of Graves' Disease: A Systematic Review and Meta-Analysis of Observational Studies

Purpose: This systematic review and meta-analysis was carried out with the aim of investigating the relationship between Foxp3 polymorphisms (rs3761547, r3761548, and rs3761549) and the risk of Graves' disease (GD). Methods: Four online database including PubMed, EMBASE, ISI Web of Science, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Han-ning, Li, Xing-rui, Du, Ya-ying, Yang, Zhi-fang, Lv, Zheng-tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308555/ https://www.ncbi.nlm.nih.gov/pubmed/32612577 http://dx.doi.org/10.3389/fendo.2020.00392

Ejemplares similares

Meta-analysis reveals significant association between FOXP3 polymorphisms and susceptibility to Graves’ disease
por: Tan, Guiqin, et al.
Publicado: (2021)

Preoperative preparation for Graves’ disease
por: Xu, Tianfeng, et al.
Publicado: (2023)

Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study
por: Struja, Tristan, et al.
Publicado: (2018)

Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review
por: Li, Jun, et al.
Publicado: (2021)

Predictive Value of Gene Polymorphisms on Recurrence after the Withdrawal of Antithyroid Drugs in Patients with Graves’ Disease
por: Liu, Jia, et al.
Publicado: (2017)

Asymmetric Graves’ Orbitopathy
por: Panagiotou, Grigorios, et al.
Publicado: (2020)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

Mechanisms That Underly T Cell Immunity in Graves’ Orbitopathy
por: Fang, Sijie, et al.
Publicado: (2021)

Immunological Features of Paranasal Sinus Mucosa in Patients with Graves’ Orbitopathy
por: Lu, Yi, et al.
Publicado: (2021)

Efficacy and Safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves’ophthalmopathy: a systematic review and meta-analysis
por: Hu, Yu, et al.
Publicado: (2023)

Antioxidant Therapy in Graves’ Orbitopathy
por: Lanzolla, Giulia, et al.
Publicado: (2020)

Orbital Signaling in Graves’ Orbitopathy
por: Draman, Mohd Shazli, et al.
Publicado: (2021)

Association Between SLC30A8 rs13266634 Polymorphism and Risk of T2DM and IGR in Chinese Population: A Systematic Review and Meta-Analysis
por: Dong, Fang, et al.
Publicado: (2018)

Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves’ Disease
por: Zheng, Dekai, et al.
Publicado: (2021)

Intestinal microbiota changes in Graves’ disease: a prospective clinical study
por: Yan, Hui-xian, et al.
Publicado: (2020)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
por: Villagelin, Danilo, et al.
Publicado: (2019)

Association of Estrogen Receptor Genes Polymorphisms With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Based on Observational Studies
por: Zhou, Siyu, et al.
Publicado: (2021)

Editorial: Mechanisms and Novel Therapies in Graves’ Orbitopathy: Current Update
por: Zhou, Huifang, et al.
Publicado: (2022)

Sphingolipids in the Heart: From Cradle to Grave
por: Kovilakath, Anna, et al.
Publicado: (2020)

Update on the surgical management of Graves’ orbitopathy
por: Baeg, Joonyoung, et al.
Publicado: (2023)

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
por: Boutzios, Georgios, et al.
Publicado: (2023)

Foxp3(+) Regulatory T Cells in Bone and Hematopoietic Homeostasis
por: Fischer, Luise, et al.
Publicado: (2019)

Compelling Evidence Linking CD40 Gene With Graves’ Disease in the Chinese Han Population
por: Jiang, He, et al.
Publicado: (2021)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Comprehensive Metabolomics Study in Children With Graves’ Disease
por: Xia, Qin, et al.
Publicado: (2021)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Current insights of applying MRI in Graves’ ophthalmopathy
por: Song, Cheng, et al.
Publicado: (2022)

GHRL Gene Leu72Met Polymorphism and Type 2 Diabetes Mellitus: A Meta-Analysis Involving 8,194 Participants
por: Li, Yan-yan, et al.
Publicado: (2019)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Graves’ Disease and Rheumatoid Arthritis: A Bidirectional Mendelian Randomization Study
por: Wu, Dide, et al.
Publicado: (2021)

Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies
por: Wang, Yining, et al.
Publicado: (2023)

Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves’ Ophthalmopathy
por: Wang, Yan, et al.
Publicado: (2022)

The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
por: Huang, LingHong, et al.
Publicado: (2022)

Association Between BAK1 Gene rs210138 Polymorphisms and Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis
por: Qin, Jiaxuan, et al.
Publicado: (2020)

Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
por: Boddu, Neeraja, et al.
Publicado: (2017)

Graves' Disease and the Post-partum Period: An Intriguing Relationship
por: Croce, Laura, et al.
Publicado: (2019)

Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020)

Therapeutic Potential of Targeting Periostin in the Treatment of Graves’ Orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2022)

Application of oral inorganic iodine in the treatment of Graves’ disease
por: Huang, Yixuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aplhbkeehmv4mgnpla5cvli672